GLSI:NASDAQGreenwich LifeSciences, Inc. Analysis
Data as of 2026-08-19 - not real-time
$17.66
Latest Price
9/10Risk
Risk Level: High
Executive Summary
The moving-average structure behind Greenwich LifeSciences, Inc. is bearish at $17.66, with short-term averages lagging the long-term ones. The last 30 days have lost 6.4%. Momentum indicators put RSI at 57.5 (neutral) with MACD reading bullish. Recent trading has carved out support near $12.51 and resistance around $18.17.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 222.8% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 92.2%, a beta of 2.91 and a maximum drawdown of 61.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Consensus targets land 222.8% above where the shares trade now.
Risk comes out at 9 of a possible 10, a high reading. With 30-day volatility of 92.2%, a beta of 2.91 and a maximum drawdown of 61.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to sell, carrying 4/10 conviction.
Top Market Events
STAFFORD, Texas, July 16, 2026 GLOBE NEWSWIRE -- Greenwich LifeSciences, Inc.STAFFORD, Texas, July 09, 2026 GLOBE NEWSWIRE -- Greenwich LifeSciences, Inc.STAFFORD, Texas, July 09, 2026 GLOBE NEWSWIRE -- Greenwich LifeSciences, Inc.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 20.63
- MACD momentum is positive
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- Short-term moving averages stacked below long-term ones
- Trading below the 200-day average of 20.63
- Analyst targets imply +222.8% versus the current price
Long Term
> 3 yearsCautious
Model confidence: 4/10
Key Factors
- Analyst targets imply +222.8% versus the current price
- Negative return on equity of -986.3%
- Negative free cash flow
Key Metrics & Analysis
Financial Health
P/E Ratio-21.5
ROE-986.32%
ROA-235.98%
P/B Ratio49.2
Op. Cash Flow$-12488140
Free Cash Flow$-3343123
Industry P/E31.2
Technical Analysis
TrendBearish
RSI57.5
Support$12.51
Resistance$18.17
MA 20$14.89
MA 50$18.29
MA 200$20.63
MACDBullish
VolumeDecreasing
Fear & Greed Index94.29
Valuation
Target Price$57.00
Upside/Downside222.76%
GradeFair
TypeGrowth
Risk Assessment
Beta2.91
Volatility92.21%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.